A detailed history of Plante Moran Financial Advisors, LLC transactions in Ensysce Biosciences, Inc. stock. As of the latest transaction made, Plante Moran Financial Advisors, LLC holds 20 shares of ENSC stock, worth $10. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20
Previous 20 -0.0%
Holding current value
$10
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023

SELL
$0.48 - $4.86 $109 - $1,108
-228 Reduced 91.94%
20 $0
Q4 2022

Feb 09, 2023

BUY
$0.62 - $3.42 $153 - $848
248 New
248 $0

Others Institutions Holding ENSC

# of Institutions
2
Shares Held
120
Call Options Held
0
Put Options Held
0

About Ensysce Biosciences, Inc.


  • Ticker ENSC
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,918,900
  • Market Cap $979K
  • Description
  • Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abu...
More about ENSC
Track This Portfolio

Track Plante Moran Financial Advisors, LLC Portfolio

Follow Plante Moran Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.